Skip to main content
  • Sign in
  • Help
BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2026
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA
Join BOPA
BOPA Join BOPA
  • Why join BOPA
  • Pricing
  • Education
    • BOPA Introduction to Cancer Course 2026
    • Courses and eLearning
    • SACT Verification Hub (Passport)
    • Resource Library
    • Cancer Hub
    • Education & Training Standards
    • Let’s Talk About SACT – a BOPA Podcast
  • About BOPA
    • About BOPA
    • Welcome to BOPA
    • Executive Committee
    • Subcommittees & working groups
    • Affiliated Groups
    • Specialist Advisory Groups
    • International Groups
    • BOPA Fellows
    • Corporate Membership
    • BOPA membership FAQs
  • Conference
    • Latest Conference 2026
    • Past Symposiums / Conferences
  • News & Events
    • News
    • Events calendar
    • Submit event
  • Menu iconLCC
    • LCC
    • Cancer Hub
  • Join BOPA

Home » Solid Tumour

Solid Tumour

BOPA encourages its members to share helpful documents that can benefit other members.  BOPA respects the intellectual property of original authors and requires anyone who uses other members’ work to include an acknowledgment of, or reference to, the source in their version.

DISCLAIMER:
BOPA is not the author or owner of some of the documents published on our website.  BOPA as a professional interest group will share documents via its website that are of interest to BOPA members, but has no responsibility for use of the documents and for any recommendations within the documents so members must use these at their discretion. BOPA cannot accept responsibility for any errors or omissions or for any consequences from application of information in the documents attached and make no warranty, expressed or implicit with respect to the contents of this webpage. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site or document(s) downloaded from it.

Posters and abstracts on the BOPA website remain the property of the authors and anyone wishing to reference or share this work must contact the authors directly. Abstracts subsequently published in JOPP follow copyright rules from JOPP.

Last reviewed: 27/04/20 by Deborah Peoples

Evaluation of palbociclib usage in patients with metastatic breast cancer at the North West Cancer Centre, Altnagelvin Area Hospital

View resources
Last reviewed: 27/04/20 by Gary L. O’Brien

Cost minimisation analysis of intravenous or subcutaneous trastuzumab treatment in patients with HER2-positive breast cancer in Ireland

View resources
Last reviewed: 27/04/20 by Suphat Subongkot

Comparative efficacy and safety of multiple interventions for brain metastases in non-small cell lung cancer: a systematic review and network meta-analysis

View resources
Last reviewed: 27/04/20 by Helen Flint

Clinical audit on the use of fulvestrant in advanced breast cancer patients

View resources
Last reviewed: 17/03/21 by Carl Booth

An evaluation of the use of adjuvant bisphosphonates in post menopausal breast cancer

Abstracts

View resources
Last reviewed: 12/10/20 by Man Hin Chu

A retrospective study on the clinical impact of gastric acid suppressants on the use of tyrosine kinase inhibitors in non-small cell lung cancer

Abstracts

View resources
Last reviewed: 14/04/20 by Colin Ward

COVID-19 Strategy for the Interim Management of Testicular Cancer Prepared by the BAUS Section of Oncology

External Documents, Guidelines

View resources
Last reviewed: 17/03/21 by Nicola Stoner

The Administration of Immunooncology Agents in UK Clinical Practice

Abstracts

View resources
Last reviewed: 10/07/19 by Natalie Ford

Is there Value in Using Patient Recorded Outcome Measures (PROMS) to Improve Toxicity Management Patients Receiving Chemotherapy for Breast Cancer?

Abstracts

View resources
Last reviewed: 10/07/19 by Faye Coe

Predictors for deferrals and dose reductions with Oxaliplatin Modified de Gramont chemotherapy (OXMDG) for colorectal cancer

Abstracts

View resources
Last reviewed: 10/07/19 by Hector Mateo-Carrasco

Incidence of neutropenia in breast cancer patients receiving fixed-dose GCSF: are we underdosing patients with higher body weights?

Abstracts

View resources
Last reviewed: 10/07/19 by Hector Mateo-Carrasco

Compared efficacy of palbociclib vs ribociclib in advanced breast cancer

Abstracts

View resources

Filter for resources

  • Types

  • Tags

  • Reset

1 2 3 Next
BOPA logo
  • Why join BOPA
  • Pricing/Join
  • Latest Conference 2026
  • Education
  • About
  • News & Events
  • Help
  • Go to LinkedIn
  • Go to Twitter
  • Go to Facebook
  • Go to Instagram
  • Go to Bluesky

© Copyright 2025 British Oncology Pharmacy Association.
Registered Charity No. 1065026

  • Privacy Policy
  • T&Cs Website
  • T&Cs Membership
  • Cookies
  • Contact
Designed and developed by Rouge
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website and also allows us to improve our site. By continuing to browse the site, you are agreeing to our use of cookies.